Conference Coverage

Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies

Publish date: May 13, 2024

 

FROM AAD 2024

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Most Cancer Trial Centers Located Closer to White, Affluent Populations
MDedge Pediatrics
Few Childhood Cancer Survivors Get Recommended Screenings
MDedge Pediatrics
A Banned Chemical That Is Still Causing Cancer
MDedge Pediatrics
Less Than 50% of Accelerated Approvals Show Clinical Benefit
MDedge Pediatrics
Oncologists Voice Ethical Concerns Over AI in Cancer Care
MDedge Pediatrics
Cannabis Constituent May Be Key to Easing THC-Induced Anxiety
MDedge Pediatrics
PCOS: Laser, Light Therapy Helpful for Hirsutism
MDedge Pediatrics
The Long, Controversial Search for a ‘Cancer Microbiome’
MDedge Pediatrics
Can a Risk Score Predict Kidney Injury After Cisplatin?
MDedge Pediatrics
New mRNA Vaccines in Development for Cancer and Infections
MDedge Pediatrics